OCT 25, 2017 10:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
WEBINAR: Antinuclear antibody screening - Making an informed decision
SPONSORED BY: Bio-Rad Laboratories
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE | Florida CE
8 15 1678

Speakers:
  • Director of Clinical Chemistry, Molecular Diagnostics, and Immunology, Lahey Hospital & Medical Center
    Biography
      In addition to his responsibilities in the clinical laboratory, Dr. Abel also serves as Instructor in Pathology, part-time, at Harvard Medical School in Boston. He has made significant contributions to HCV research with a seminal study demonstrating the use of LDL receptor by the virus as a port of entry into hepatocytes. Gyorgy completed residency at the Massachusetts General Hospital, and became board certified in Clinical Pathology and in Molecular Diagnostics. He is a Fellow of the Academy of the American Association for Clinical Chemistry (AACC), where he was recently elected as Council Member. He also serves on the Diagnostic Immunology Resource Committee of the College of American Pathologists and the Clinical and Translational Research Subcommittee of the Federation of American Societies for Experimental Biology (FASEB). He is an Overseas Member of the Royal Society of Medicine (U.K.) and the Clinical Advisory Committee of the Reference Material Institute for Clinical Chemistry Standards in Japan. Dr. Abel is the Past Chair of the Clinical Immunology Division of the AACC, former Vice President of the American Board of Clinical Chemistry, and former member of the Clinical Immunology Committee of the American Association of Immunologists. He is the author or co-author of over 100 articles, book chapters, and scientific conference presentations, and a regular reviewer for scientific journals.
    • Co-Director, Antibody Immunology Laboratory, Mayo Clinic
      Biography
        Melissa R. Snyder, PhD completed her doctoral degree in Biochemistry through the Mayo Graduate School in 1997. She followed that with a post-doctoral fellowship in clinical/basic immunology, during which time she studied T-cell function in autoimmune disease, specifically rheumatoid arthritis. She then completed a clinical chemistry fellowship at the Mayo Clinic, where she focused on laboratory diagnostics and autoimmune disease. After completing her clinical fellowship, she was board-certified in Clinical Chemistry by the American Board of Clinical Chemistry. Dr. Snyder is currently Co-Director of the Antibody Immunology Laboratory at the Mayo Clinic, with an academic appointment as Associate Professor of Laboratory Medicine and Pathology. The Antibody Immunology Lab performs clinical testing that aids in the diagnosis of a variety of autoimmune diseases, which allows Dr. Snyder to continue to pursue her long-standing interest in autoimmunity. Throughout her career, Dr. Snyder has been active in a number of scientific societies, supporting their efforts to promote the field of clinical laboratory immunology. From 2009 to 2013, she served as a liaison from American Association for Clinical Chemistry (AACC) to the College of American Pathologist's Diagnostic Immunology Resource Committee. Also through AACC, Dr. Snyder has been an active member of the Clinical and Diagnostic Immunology Division, having served as the Education Officer (2013-2016) and as Chair-Elect (2016-present). Dr. Snyder is also a member of the Association of Medical Laboratory Immunologists (AMLI), and has served as Councilor on the Executive Committee from 2014-2015. Her goal is to provide educational opportunities, to raise awareness among laboratorians and clinicians about the challenges and opportunities that exist within the diagnostic immunology laboratory, and to attract new scientists and investigators to the area of clinical immunology.

      Abstract:

      DATE: October 25, 2017
      TIME: 10:00am PDT, 1:00pm EDT

      Testing for antinuclear antibodies (ANAs) has been a routine part of the evaluation of patients with a suspected connective tissue disease (CTD) for the last 50 years. Dr. Melissa Snyder and Dr. Gyorgy Abel will present the methods for ANA testing available to the clinical laboratory today as well as current ANA testing guidelines and examples of algorithms in use. Dr. Snyder will present findings from her study comparing various ANA methods and Dr. Abel will share his laboratory’s experience in implementing one of the newer methods for ANA testing. The speakers will provide valuable information to help you make an informed decision for your laboratory when choosing methods for ANA testing.

      Learning Objectives:

      • List the methods available to the clinical laboratory for general ANA testing.
      • Describe ANA testing guidelines and algorithms and the current trends in testing.
      • Describe how the various ANA methods compare in terms of analytical characteristics and clinical utility.

      Show Resources
      Loading Comments...
      Show Resources
      Event Countdown
      • 0 Days
      • 0 Hours
      • 0 Minutes
      • 0 Seconds